Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant leucocyte α-A interferon
- 31 December 1986
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 3, S245-S251
- https://doi.org/10.1016/s0168-8278(86)80128-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replicationLiver International, 1984
- Acute Dane Particle Suppression with Recombinant Leukocyte A Interferon in Chronic Hepatitis B Virus InfectionThe Journal of Infectious Diseases, 1983
- Therapeutic Effect of a Low Dosage of Human Leukocyte Interferon on Chronic Hepatitis B Virus InfectionDigestion, 1983
- Adenine Arabinoside 5′–Monophosphate Treatment of Chronic Type B HepatitisHepatology, 1982
- Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).Gut, 1982
- Integration of Hepatitis B Virus DNA into the Genome of Liver Cells in Chronic Liver Disease and Hepatocellular CarcinomaNew England Journal of Medicine, 1981
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981
- Chronic active hepatitisDigestive Diseases and Sciences, 1980
- SERUM LEVELS OF HEPATITIS B SURFACE AND CORE ANTIGENS DURING IMMUNOSUPPRESSIVE TREATMENT OF HBsAg-POSITIVE CHRONIC ACTIVE HEPATITISThe Lancet, 1980
- ADMINISTRATION OF HUMAN FIBROBLAST INTERFERON IN CHRONIC HEPATITIS-B INFECTIONThe Lancet, 1976